ClinicalTrials.gov record
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
ClinicalTrials.gov ID: NCT01650805
Public ClinicalTrials.gov record NCT01650805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized,Open-Label Study of Ponatinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Study identification
- NCT ID
- NCT01650805
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Ariad Pharmaceuticals
- Industry
- Enrollment
- 307 participants
Conditions and interventions
Conditions
Interventions
- imatinib (Gleevec/ Glivec) Drug
- ponatinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2012
- Primary completion
- Sep 30, 2013
- Completion
- Sep 30, 2013
- Last update posted
- Nov 16, 2014
2012 – 2013
United States locations
- U.S. sites
- 67
- U.S. states
- 34
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| US Oncology - Providence Health System, Site #167 | Burbank | California | 91505 | — |
| UCLA Department of Medicine, Site #027 | Los Angeles | California | 90095 | — |
| Bay Area Cancer Research Group, Site #156 | Pleasant Hill | California | 94523 | — |
| Bay Area Cancer Research Group, Site #157 | Pleasant Hill | California | 94523 | — |
| Rocky Mountain Cancer Centers, Site #191 | Boulder | Colorado | 80303 | — |
| Cancer Center of Central Connecticut, Site #147 | Southington | Connecticut | 06489 | — |
| Christiana Care Health Services, Site #155 | Newark | Delaware | 19713 | — |
| University Cancer Institute, Site #149 | Boynton Beach | Florida | 33426 | — |
| Florida Cancer Specialists, Site #180 | Fort Meyers | Florida | 33916 | — |
| Florida Cancer Specialists, Site #179 | St. Petersburg | Florida | 33705 | — |
| Emory University, Site #058 | Atlanta | Georgia | 30322 | — |
| John H. Stroger, Jr. Hospital of Cook County, Site #192 | Chicago | Illinois | 60612 | — |
| University of Chicago, Site #001 | Chicago | Illinois | 60637 | — |
| Loyola University Chicago, Site #054 | Maywood | Illinois | 60153 | — |
| Franciscan St. Francis Health, Site #138 | Indianapolis | Indiana | 46237 | — |
| University of Iowa Hospitals and Clinics, Site #050 | Iowa City | Iowa | 52242 | — |
| Siouxland Hematology-Oncology Associates, Site #198 | Sioux City | Iowa | 51101 | — |
| US Oncology - Cancer Center of Kansas, Site #168 | Wichita | Kansas | 67214 | — |
| Willis-Knighton Cancer Center, Site #196 | Shreveport | Louisiana | 71103 | — |
| University of Maryland, Greenebaum Cancer Center, Site #040 | Baltimore | Maryland | 21201 | — |
| Greater Baltimore Medical Center, Site #140 | Baltimore | Maryland | 21204 | — |
| St. Agnes Healthcare, Site #185 | Baltimore | Maryland | 21229 | — |
| Massachusetts General Hospital, Site #047 | Boston | Massachusetts | 02114 | — |
| Dana Farber Cancer Institute, Site #008 | Boston | Massachusetts | 02215 | — |
| University of Massachusetts Worcester, Site #152 | Worcester | Massachusetts | 01655 | — |
| University of Michigan Medical Center, Site #011 | Ann Arbor | Michigan | 48109 | — |
| Providence Cancer Institute, Site #197 | Southfield | Michigan | 48075 | — |
| Mayo Clinic, Site #044 | Rochester | Minnesota | 55905 | — |
| Oncology Research Park Nicollet Institute, Site #195 | Saint Louis Park | Minnesota | 55426 | — |
| Saint Luke's Hospital, Site #162 | Kansas City | Missouri | 64111 | — |
| Mercy Clinic - Cancer & Hematology, Site #151 | Springfield | Missouri | 65804 | — |
| Nebraska Hematology-Oncology, P.C., Site # 133 | Lincoln | Nebraska | 68506 | — |
| US Oncology - Comprehensive Cancer Center of Nevada, Site #169 | Las Vegas | Nevada | 89169 | — |
| John Theurer Cancer Center, Site #128 | Hackensack | New Jersey | 07601 | — |
| University of New Mexico Cancer Center, Site #166 | Albuquerque | New Mexico | 87106 | — |
| Maimonides Cancer Center, Site #177 | Brooklyn | New York | 11220 | — |
| Winthrop University Hospital, Site #153 | Mineola | New York | 11501 | — |
| Beth Israel Medical Center, Site #145 | New York | New York | 10003 | — |
| Mount Sinai School of Medicine, Site #189 | New York | New York | 10029 | — |
| Memorial Sloan-Kettering Cancer Center, Site #078 | New York | New York | 10065 | — |
| Weill Cornell Medical College, Site #006 | New York | New York | 10065 | — |
| New York Medical College, Site #146 | Valhalla | New York | 10595 | — |
| Southeastern Medical Oncology Center, Site #188 | Goldsboro | North Carolina | 27534 | — |
| Signal Point Clinical Research Center, Site #139 | Middletown | Ohio | 45042 | — |
| University of Oklahoma, Site #028 | Oklahoma City | Oklahoma | 73104 | — |
| Providence Cancer Center Oncology and Hematology Care Eastside, Site #194 | Portland | Oregon | 97213 | — |
| Kaiser Permanente Northwest, Site #200 | Portland | Oregon | 97227 | — |
| Oregon Health & Science University, Site #048 | Portland | Oregon | 97239 | — |
| Gettysburg Cancer Center, Site #160 | Gettysburg | Pennsylvania | 17325 | — |
| Western Pennsylvania Hospital, Site #159 | Pittsburgh | Pennsylvania | 15224 | — |
| Medical University of South Carolina, Site #148 | Charleston | South Carolina | 29425 | — |
| Carolina Hematology Oncology, Site #143 | Sumter | South Carolina | 29150 | — |
| Associates in Oncology & Hematology, Site #186 | Chattanooga | Tennessee | 37421 | — |
| Sarah Cannon Research Institute, Site #076 | Nashville | Tennessee | 37203 | — |
| US Oncology - Texas Oncology Austin, Site #172 | Austin | Texas | 78705 | — |
| US Oncology - Texas Oncology Dallas, Site #171 | Dallas | Texas | 75231 | — |
| University of Texas Southwestern Medical Center, Site #178 | Dallas | Texas | 75390 | — |
| Baylor College of Medicine, Site #063 | Houston | Texas | 77030 | — |
| US Oncology - Texas Oncology Midland, Site #173 | Midland | Texas | 79701 | — |
| US Oncology - Cancer Care Center of South Texas, Site #170 | San Antonio | Texas | 78229 | — |
| Huntsman Cancer Institute, Site #043 | Salt Lake City | Utah | 84112 | — |
| VCU Massey Cancer Center, Dalton Oncology Clinic, Site #069 | Richmond | Virginia | 23298 | — |
| Seattle Cancer Care Alliance, Site #100 | Seattle | Washington | 98109 | — |
| US Oncology - Northwest Cancer Specialists, Site #174 | Vancouver | Washington | 98684 | — |
| West Virginia University, Site #154 | Morgantown | West Virginia | 26506 | — |
| Green Bay Oncology, Ltd. / St. Mary's Hospital Medical Center, Site #193 | Green Bay | Wisconsin | 54303 | — |
| University of Wisconsin, Site #030 | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 103 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01650805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2014 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01650805 live on ClinicalTrials.gov.